Drug interactions for the following drug(s)

Interactions between your selected drugs

The risk or severity of adverse effects can be increased when Baclofen is combined with Paroxetine.

The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Fenofibrate is combined with Leflunomide.

The therapeutic efficacy of Baclofen can be increased when used in combination with Pregabalin.

The risk or severity of hypoglycemia can be increased when Fenofibrate is combined with Glipizide.

The metabolism of Glipizide can be decreased when combined with Paroxetine.

The therapeutic efficacy of Glipizide can be increased when used in combination with Ciprofloxacin.

The therapeutic efficacy of Paroxetine can be increased when used in combination with Pregabalin.

The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Leflunomide.

Sucralfate may decrease the excretion rate of Lamotrigine which could result in a higher serum level.

Omeprazole may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.

The metabolism of Fenofibrate can be decreased when combined with Mirtazapine.

Pregabalin may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.

Paroxetine may increase the serotonergic activities of Mirtazapine.

The metabolism of Leflunomide can be decreased when combined with Ciprofloxacin.

Mirtazapine may increase the central nervous system depressant (CNS depressant) activities of Lamotrigine.

The risk or severity of hypoglycemia can be increased when Pregabalin is combined with Glipizide.

The metabolism of Glipizide can be decreased when combined with Omeprazole.

The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Fenofibric acid.

The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Rosuvastatin.

The metabolism of Fenofibrate can be increased when combined with Omeprazole.

The metabolism of Rosuvastatin can be decreased when combined with Mirtazapine.

Baclofen may decrease the excretion rate of Sucralfate which could result in a higher serum level.

The metabolism of Mirtazapine can be decreased when combined with Ciprofloxacin.

Pregabalin may decrease the excretion rate of Sucralfate which could result in a higher serum level.

Sucralfate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.

The risk or severity of adverse effects can be increased when Fenofibrate is combined with Fenofibric acid.

The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Rosuvastatin.

The metabolism of Fenofibrate can be decreased when combined with Paroxetine.

The risk or severity of QTc prolongation can be increased when Lamotrigine is combined with Ciprofloxacin.

The therapeutic efficacy of Glipizide can be increased when used in combination with Rosuvastatin.

The serum concentration of Mirtazapine can be decreased when it is combined with Leflunomide.

The risk or severity of adverse effects can be increased when Lamotrigine is combined with Paroxetine.

The risk or severity of adverse effects can be increased when Baclofen is combined with Lamotrigine.

Sucralfate may decrease the excretion rate of Glipizide which could result in a higher serum level.

The therapeutic efficacy of Mirtazapine can be increased when used in combination with Pregabalin.

The metabolism of Paroxetine can be decreased when combined with Ciprofloxacin.

The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Ciprofloxacin.

sucralfate<>fenofibric acid

Applies to: sucralfate 1 GM Oral Tablet <> Fenofibrate 145 MG Oral Tablet

Sucralfate may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.

Sucralfate may decrease the excretion rate of Fenofibrate which could result in a higher serum level.

Omeprazole may decrease the excretion rate of Leflunomide which could result in a higher serum level.

The metabolism of Rosuvastatin can be decreased when combined with Paroxetine.

The therapeutic efficacy of Glipizide can be decreased when used in combination with Baclofen.

The metabolism of Glipizide can be decreased when combined with Leflunomide.

ciprofloxacin<>fenofibric acid

Applies to: Ciprofloxacin 500 MG Oral Tablet <> Fenofibrate 145 MG Oral Tablet

The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ciprofloxacin is combined with Fenofibric acid.

Baclofen may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.

The metabolism of Mirtazapine can be increased when combined with Omeprazole.

The risk or severity of QTc prolongation can be increased when Pregabalin is combined with Ciprofloxacin.

The risk or severity of myopathy and rhabdomyolysis can be increased when Fenofibric acid is combined with Rosuvastatin.

The metabolism of Omeprazole can be decreased when combined with Paroxetine.

The serum concentration of Rosuvastatin can be increased when it is combined with Leflunomide.

Lamotrigine may decrease the excretion rate of Fenofibric acid which could result in a higher serum level.

The metabolism of Glipizide can be increased when combined with Lamotrigine.

No other interactions were found between your selected drugs.

Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.

Interactions between your selected drugs

Drug1 (rxcui = 197391, name = baclofen 10 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1738495, name = paroxetine hydrochloride 20 MG Oral Tablet, tty = SCD). Drug1 is resolved to baclofen, Drug2 is resolved to paroxetine and interaction asserted in DrugBank between Baclofen and Paroxetine.

Drug1 (rxcui = 477560, name = fenofibrate 145 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 205284, name = leflunomide 10 MG Oral Tablet, tty = SCD). Drug1 is resolved to fenofibrate, Drug2 is resolved to leflunomide and interaction asserted in DrugBank between Fenofibrate and Leflunomide. Drug1 is resolved to fenofibric acid, Drug2 is resolved to leflunomide and interaction asserted in DrugBank between Fenofibric acid and Leflunomide.

Drug1 (rxcui = 197391, name = baclofen 10 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 483438, name = pregabalin 100 MG Oral Capsule, tty = SCD). Drug1 is resolved to baclofen, Drug2 is resolved to pregabalin and interaction asserted in DrugBank between Baclofen and Pregabalin.

Drug1 (rxcui = 310490, name = glipizide 5 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 477560, name = fenofibrate 145 MG Oral Tablet, tty = SCD). Drug1 is resolved to glipizide, Drug2 is resolved to fenofibrate and interaction asserted in DrugBank between Glipizide and Fenofibrate. Drug1 is resolved to glipizide, Drug2 is resolved to fenofibric acid and interaction asserted in DrugBank between Glipizide and Fenofibric acid.

Drug1 (rxcui = 310490, name = glipizide 5 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1738495, name = paroxetine hydrochloride 20 MG Oral Tablet, tty = SCD). Drug1 is resolved to glipizide, Drug2 is resolved to paroxetine and interaction asserted in DrugBank between Glipizide and Paroxetine.

Drug1 (rxcui = 309309, name = ciprofloxacin 500 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 310490, name = glipizide 5 MG Oral Tablet, tty = SCD). Drug1 is resolved to ciprofloxacin, Drug2 is resolved to glipizide and interaction asserted in DrugBank between Ciprofloxacin and Glipizide.

Drug1 (rxcui = 1738495, name = paroxetine hydrochloride 20 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 483438, name = pregabalin 100 MG Oral Capsule, tty = SCD). Drug1 is resolved to paroxetine, Drug2 is resolved to pregabalin and interaction asserted in DrugBank between Paroxetine and Pregabalin.

Drug1 (rxcui = 197391, name = baclofen 10 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 205284, name = leflunomide 10 MG Oral Tablet, tty = SCD). Drug1 is resolved to baclofen, Drug2 is resolved to leflunomide and interaction asserted in DrugBank between Baclofen and Leflunomide.

Drug1 (rxcui = 314234, name = sucralfate 1000 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 103968, name = lamotrigine 100 MG Disintegrating Oral Tablet, tty = SCD). Drug1 is resolved to sucralfate, Drug2 is resolved to lamotrigine and interaction asserted in DrugBank between Sucralfate and Lamotrigine.

Drug1 (rxcui = 402014, name = omeprazole 20 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 859419, name = rosuvastatin calcium 40 MG Oral Tablet, tty = SCD). Drug1 is resolved to omeprazole, Drug2 is resolved to rosuvastatin and interaction asserted in DrugBank between Omeprazole and Rosuvastatin.

Drug1 (rxcui = 477560, name = fenofibrate 145 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 211322, name = mirtazapine 15 MG Oral Tablet [Remeron], tty = SBD). Drug1 is resolved to fenofibrate, Drug2 is resolved to mirtazapine and interaction asserted in DrugBank between Fenofibrate and Mirtazapine.

Drug1 (rxcui = 477560, name = fenofibrate 145 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 483438, name = pregabalin 100 MG Oral Capsule, tty = SCD). Drug1 is resolved to fenofibric acid, Drug2 is resolved to pregabalin and interaction asserted in DrugBank between Fenofibric acid and Pregabalin. Drug1 is resolved to fenofibrate, Drug2 is resolved to pregabalin and interaction asserted in DrugBank between Fenofibrate and Pregabalin.

Drug1 (rxcui = 211322, name = mirtazapine 15 MG Oral Tablet [Remeron], tty = SBD). Drug2 (rxcui = 1738495, name = paroxetine hydrochloride 20 MG Oral Tablet, tty = SCD). Drug1 is resolved to mirtazapine, Drug2 is resolved to paroxetine and interaction asserted in DrugBank between Mirtazapine and Paroxetine.

Drug1 (rxcui = 309309, name = ciprofloxacin 500 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 205284, name = leflunomide 10 MG Oral Tablet, tty = SCD). Drug1 is resolved to ciprofloxacin, Drug2 is resolved to leflunomide and interaction asserted in DrugBank between Ciprofloxacin and Leflunomide.

Drug1 (rxcui = 211322, name = mirtazapine 15 MG Oral Tablet [Remeron], tty = SBD). Drug2 (rxcui = 103968, name = lamotrigine 100 MG Disintegrating Oral Tablet, tty = SCD). Drug1 is resolved to mirtazapine, Drug2 is resolved to lamotrigine and interaction asserted in DrugBank between Mirtazapine and Lamotrigine.

Drug1 (rxcui = 310490, name = glipizide 5 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 483438, name = pregabalin 100 MG Oral Capsule, tty = SCD). Drug1 is resolved to glipizide, Drug2 is resolved to pregabalin and interaction asserted in DrugBank between Glipizide and Pregabalin.

Drug1 (rxcui = 310490, name = glipizide 5 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 402014, name = omeprazole 20 MG Delayed Release Oral Tablet, tty = SCD). Drug1 is resolved to glipizide, Drug2 is resolved to omeprazole and interaction asserted in DrugBank between Glipizide and Omeprazole.

Drug1 (rxcui = 197391, name = baclofen 10 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 477560, name = fenofibrate 145 MG Oral Tablet, tty = SCD). Drug1 is resolved to baclofen, Drug2 is resolved to fenofibric acid and interaction asserted in DrugBank between Baclofen and Fenofibric acid. Drug1 is resolved to baclofen, Drug2 is resolved to fenofibrate and interaction asserted in DrugBank between Baclofen and Fenofibrate.

Drug1 (rxcui = 197391, name = baclofen 10 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 859419, name = rosuvastatin calcium 40 MG Oral Tablet, tty = SCD). Drug1 is resolved to baclofen, Drug2 is resolved to rosuvastatin and interaction asserted in DrugBank between Baclofen and Rosuvastatin.

Drug1 (rxcui = 402014, name = omeprazole 20 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 477560, name = fenofibrate 145 MG Oral Tablet, tty = SCD). Drug1 is resolved to omeprazole, Drug2 is resolved to fenofibrate and interaction asserted in DrugBank between Omeprazole and Fenofibrate.

Drug1 (rxcui = 211322, name = mirtazapine 15 MG Oral Tablet [Remeron], tty = SBD). Drug2 (rxcui = 859419, name = rosuvastatin calcium 40 MG Oral Tablet, tty = SCD). Drug1 is resolved to mirtazapine, Drug2 is resolved to rosuvastatin and interaction asserted in DrugBank between Mirtazapine and Rosuvastatin.

Drug1 (rxcui = 197391, name = baclofen 10 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 314234, name = sucralfate 1000 MG Oral Tablet, tty = SCD). Drug1 is resolved to baclofen, Drug2 is resolved to sucralfate and interaction asserted in DrugBank between Baclofen and Sucralfate.

Drug1 (rxcui = 309309, name = ciprofloxacin 500 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 211322, name = mirtazapine 15 MG Oral Tablet [Remeron], tty = SBD). Drug1 is resolved to ciprofloxacin, Drug2 is resolved to mirtazapine and interaction asserted in DrugBank between Ciprofloxacin and Mirtazapine.

Drug1 (rxcui = 314234, name = sucralfate 1000 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 483438, name = pregabalin 100 MG Oral Capsule, tty = SCD). Drug1 is resolved to sucralfate, Drug2 is resolved to pregabalin and interaction asserted in DrugBank between Sucralfate and Pregabalin.

Drug1 (rxcui = 309309, name = ciprofloxacin 500 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 314234, name = sucralfate 1000 MG Oral Tablet, tty = SCD). Drug1 is resolved to ciprofloxacin, Drug2 is resolved to sucralfate and interaction asserted in DrugBank between Ciprofloxacin and Sucralfate.

Drug1 (rxcui = 477560, name = fenofibrate 145 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 477560, name = fenofibrate 145 MG Oral Tablet, tty = SCD). Drug1 is resolved to fenofibrate, Drug2 is resolved to fenofibric acid and interaction asserted in DrugBank between Fenofibrate and Fenofibric acid. Drug1 is resolved to fenofibric acid, Drug2 is resolved to fenofibrate and interaction asserted in DrugBank between Fenofibric acid and Fenofibrate.

Drug1 (rxcui = 309309, name = ciprofloxacin 500 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 859419, name = rosuvastatin calcium 40 MG Oral Tablet, tty = SCD). Drug1 is resolved to ciprofloxacin, Drug2 is resolved to rosuvastatin and interaction asserted in DrugBank between Ciprofloxacin and Rosuvastatin.

Drug1 (rxcui = 477560, name = fenofibrate 145 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1738495, name = paroxetine hydrochloride 20 MG Oral Tablet, tty = SCD). Drug1 is resolved to fenofibrate, Drug2 is resolved to paroxetine and interaction asserted in DrugBank between Fenofibrate and Paroxetine.

Drug1 (rxcui = 309309, name = ciprofloxacin 500 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 103968, name = lamotrigine 100 MG Disintegrating Oral Tablet, tty = SCD). Drug1 is resolved to ciprofloxacin, Drug2 is resolved to lamotrigine and interaction asserted in DrugBank between Ciprofloxacin and Lamotrigine.

Drug1 (rxcui = 310490, name = glipizide 5 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 859419, name = rosuvastatin calcium 40 MG Oral Tablet, tty = SCD). Drug1 is resolved to glipizide, Drug2 is resolved to rosuvastatin and interaction asserted in DrugBank between Glipizide and Rosuvastatin.

Drug1 (rxcui = 211322, name = mirtazapine 15 MG Oral Tablet [Remeron], tty = SBD). Drug2 (rxcui = 205284, name = leflunomide 10 MG Oral Tablet, tty = SCD). Drug1 is resolved to mirtazapine, Drug2 is resolved to leflunomide and interaction asserted in DrugBank between Mirtazapine and Leflunomide.

Drug1 (rxcui = 103968, name = lamotrigine 100 MG Disintegrating Oral Tablet, tty = SCD). Drug2 (rxcui = 1738495, name = paroxetine hydrochloride 20 MG Oral Tablet, tty = SCD). Drug1 is resolved to lamotrigine, Drug2 is resolved to paroxetine and interaction asserted in DrugBank between Lamotrigine and Paroxetine.

Drug1 (rxcui = 197391, name = baclofen 10 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 103968, name = lamotrigine 100 MG Disintegrating Oral Tablet, tty = SCD). Drug1 is resolved to baclofen, Drug2 is resolved to lamotrigine and interaction asserted in DrugBank between Baclofen and Lamotrigine.

Drug1 (rxcui = 310490, name = glipizide 5 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 314234, name = sucralfate 1000 MG Oral Tablet, tty = SCD). Drug1 is resolved to glipizide, Drug2 is resolved to sucralfate and interaction asserted in DrugBank between Glipizide and Sucralfate.

Drug1 (rxcui = 211322, name = mirtazapine 15 MG Oral Tablet [Remeron], tty = SBD). Drug2 (rxcui = 483438, name = pregabalin 100 MG Oral Capsule, tty = SCD). Drug1 is resolved to mirtazapine, Drug2 is resolved to pregabalin and interaction asserted in DrugBank between Mirtazapine and Pregabalin.

Drug1 (rxcui = 309309, name = ciprofloxacin 500 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 1738495, name = paroxetine hydrochloride 20 MG Oral Tablet, tty = SCD). Drug1 is resolved to ciprofloxacin, Drug2 is resolved to paroxetine and interaction asserted in DrugBank between Ciprofloxacin and Paroxetine.

Drug1 (rxcui = 197391, name = baclofen 10 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 309309, name = ciprofloxacin 500 MG Oral Tablet, tty = SCD). Drug1 is resolved to baclofen, Drug2 is resolved to ciprofloxacin and interaction asserted in DrugBank between Baclofen and Ciprofloxacin.

sucralfate<>fenofibric acid

Applies to: sucralfate 1 GM Oral Tablet <> Fenofibrate 145 MG Oral Tablet

Drug1 (rxcui = 314234, name = sucralfate 1000 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 477560, name = fenofibrate 145 MG Oral Tablet, tty = SCD). Drug1 is resolved to sucralfate, Drug2 is resolved to fenofibric acid and interaction asserted in DrugBank between Sucralfate and Fenofibric acid.

Drug1 (rxcui = 477560, name = fenofibrate 145 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 314234, name = sucralfate 1000 MG Oral Tablet, tty = SCD). Drug1 is resolved to fenofibrate, Drug2 is resolved to sucralfate and interaction asserted in DrugBank between Fenofibrate and Sucralfate.

Drug1 (rxcui = 402014, name = omeprazole 20 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 205284, name = leflunomide 10 MG Oral Tablet, tty = SCD). Drug1 is resolved to omeprazole, Drug2 is resolved to leflunomide and interaction asserted in DrugBank between Omeprazole and Leflunomide.

Drug1 (rxcui = 1738495, name = paroxetine hydrochloride 20 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 859419, name = rosuvastatin calcium 40 MG Oral Tablet, tty = SCD). Drug1 is resolved to paroxetine, Drug2 is resolved to rosuvastatin and interaction asserted in DrugBank between Paroxetine and Rosuvastatin.

Drug1 (rxcui = 197391, name = baclofen 10 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 310490, name = glipizide 5 MG Oral Tablet, tty = SCD). Drug1 is resolved to baclofen, Drug2 is resolved to glipizide and interaction asserted in DrugBank between Baclofen and Glipizide.

Drug1 (rxcui = 310490, name = glipizide 5 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 205284, name = leflunomide 10 MG Oral Tablet, tty = SCD). Drug1 is resolved to glipizide, Drug2 is resolved to leflunomide and interaction asserted in DrugBank between Glipizide and Leflunomide.

Drug1 (rxcui = 309309, name = ciprofloxacin 500 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 477560, name = fenofibrate 145 MG Oral Tablet, tty = SCD). Drug1 is resolved to ciprofloxacin, Drug2 is resolved to fenofibric acid and interaction asserted in DrugBank between Ciprofloxacin and Fenofibric acid. Drug1 is resolved to ciprofloxacin, Drug2 is resolved to fenofibrate and interaction asserted in DrugBank between Ciprofloxacin and Fenofibrate.

Drug1 (rxcui = 197391, name = baclofen 10 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 211322, name = mirtazapine 15 MG Oral Tablet [Remeron], tty = SBD). Drug1 is resolved to baclofen, Drug2 is resolved to mirtazapine and interaction asserted in DrugBank between Baclofen and Mirtazapine.

Drug1 (rxcui = 402014, name = omeprazole 20 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 211322, name = mirtazapine 15 MG Oral Tablet [Remeron], tty = SBD). Drug1 is resolved to omeprazole, Drug2 is resolved to mirtazapine and interaction asserted in DrugBank between Omeprazole and Mirtazapine.

Drug1 (rxcui = 309309, name = ciprofloxacin 500 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 483438, name = pregabalin 100 MG Oral Capsule, tty = SCD). Drug1 is resolved to ciprofloxacin, Drug2 is resolved to pregabalin and interaction asserted in DrugBank between Ciprofloxacin and Pregabalin.

Drug1 (rxcui = 477560, name = fenofibrate 145 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 859419, name = rosuvastatin calcium 40 MG Oral Tablet, tty = SCD). Drug1 is resolved to fenofibric acid, Drug2 is resolved to rosuvastatin and interaction asserted in DrugBank between Fenofibric acid and Rosuvastatin. Drug1 is resolved to fenofibrate, Drug2 is resolved to rosuvastatin and interaction asserted in DrugBank between Fenofibrate and Rosuvastatin.

Drug1 (rxcui = 402014, name = omeprazole 20 MG Delayed Release Oral Tablet, tty = SCD). Drug2 (rxcui = 1738495, name = paroxetine hydrochloride 20 MG Oral Tablet, tty = SCD). Drug1 is resolved to omeprazole, Drug2 is resolved to paroxetine and interaction asserted in DrugBank between Omeprazole and Paroxetine.

Drug1 (rxcui = 205284, name = leflunomide 10 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 859419, name = rosuvastatin calcium 40 MG Oral Tablet, tty = SCD). Drug1 is resolved to leflunomide, Drug2 is resolved to rosuvastatin and interaction asserted in DrugBank between Leflunomide and Rosuvastatin.

Drug1 (rxcui = 477560, name = fenofibrate 145 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 103968, name = lamotrigine 100 MG Disintegrating Oral Tablet, tty = SCD). Drug1 is resolved to fenofibric acid, Drug2 is resolved to lamotrigine and interaction asserted in DrugBank between Fenofibric acid and Lamotrigine. Drug1 is resolved to fenofibrate, Drug2 is resolved to lamotrigine and interaction asserted in DrugBank between Fenofibrate and Lamotrigine.

Drug1 (rxcui = 310490, name = glipizide 5 MG Oral Tablet, tty = SCD). Drug2 (rxcui = 103968, name = lamotrigine 100 MG Disintegrating Oral Tablet, tty = SCD). Drug1 is resolved to glipizide, Drug2 is resolved to lamotrigine and interaction asserted in DrugBank between Glipizide and Lamotrigine.

No other interactions were found between your selected drugs.

Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.